Skip to main content
ZIM Laboratories Limited logo

ZIM Laboratories Limited — Investor Relations & Filings

Ticker · ZIMLAB ISIN · INE518E01015 LEI · 335800YPYG1O3ML66R52 BSE.NS Manufacturing
Open in API
Filings indexed 423 across all filing types
Latest filing 2023-11-22 Regulatory Filings
Country IN India
Listing BSE.NS ZIMLAB

About ZIM Laboratories Limited

https://www.zimlab.in/

ZIM Laboratories Limited is a research-driven organization specializing in the development and manufacturing of innovative drug delivery solutions. The company focuses on enhancing the efficacy and patient compliance of generic medicines through advanced formulation technologies. Its core product portfolio includes Oral Disintegrating Films (ODF), Oral Disintegrating Tablets (ODT), pellets, and taste-masked granules. Utilizing proprietary technology platforms like Thinoral, the company provides differentiated products across various therapeutic segments, including central nervous system, cardiovascular, and gastrointestinal health. ZIM Laboratories offers end-to-end services from product development and clinical trials to commercial manufacturing. The organization serves a global clientele, providing value-added generic formulations that address specific patient needs such as ease of administration and rapid onset of action.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice addressed to stock exchanges regarding the schedule of an Investors / Analysts Meet. It references compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The document does not contain financial statements, detailed financial data, or a report itself. It is an announcement of a meeting schedule, not a report or transcript. The document length is only 2137 characters, which is short and typical for a regulatory announcement. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-11-22 English
Loss of Share Certificates
Share Issue/Capital Change Classification · 95% confidence The document is a formal communication addressed to stock exchanges (BSE and NSE) regarding the issuance of a duplicate share certificate to a shareholder. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 39(3), which deals with share certificate matters. The content is about notifying the exchanges of a corporate action related to share certificates, not a financial report, management change, or earnings release. The document length is short (2179 characters) and it is an announcement of a specific corporate action (duplicate share certificate issuance). This fits the category of Share Issue/Capital Change (SHA), as it relates to changes in share certificates and capital records.
2023-11-21 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short disclosure letter addressed to stock exchanges regarding the schedule of an Investors/Analysts Meet. It references compliance with Regulation 30 of SEBI (LODR) Regulations, 2015, which pertains to disclosure obligations. The document does not contain any financial data, detailed presentations, or reports but simply informs about the timing and nature of an upcoming meeting. The length is only 2139 characters, indicating it is a brief announcement rather than a full report or transcript. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-11-21 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding the loss of share certificates and the subsequent stop transfer of those shares until duplicate certificates are issued. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 39(3), which pertains to share certificate loss and transfer restrictions. The content is an official notification about share certificate status and does not contain financial data, earnings, management discussion, or any report publication. It is not a report or announcement of financial results, nor is it related to board changes, voting results, or capital changes. This type of document fits best under Regulatory Filings (RNS), which covers miscellaneous compliance and regulatory announcements that do not fit other categories.
2023-11-17 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 100% confidence The document is a detailed transcript of the Q2 and H1 FY24 earnings conference call of ZIM Laboratories Limited. It includes management presentations of financial results, business updates, and a Q&A session with analysts and investors. The text explicitly mentions it is a transcript of the earnings conference call held on November 9, 2023, discussing quarterly financial performance, revenue, margins, product updates, and outlook. This matches the definition of a Call Transcript (CT), which is a full text transcript of company conference calls such as earnings calls with Q&A. The document length is substantial (15,000 characters), and it contains the full transcript, not just an announcement or summary. Therefore, the correct classification is CT with high confidence.
2023-11-15 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short letter dated 09.11.2023 addressed to stock exchanges, informing them about the availability of the audio recording of the Q2 & H1FY24 Earnings Conference Call on the company's website. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, which pertains to disclosure requirements. The document does not contain the transcript or detailed financial data but merely announces the availability of the earnings call recording. The length is only 2174 characters, which is short and consistent with an announcement rather than a full report or transcript. According to the rules, announcements about earnings calls or their recordings fall under Regulatory Filings (RNS) if they do not contain the transcript or detailed financial data. Therefore, the appropriate classification is Regulatory Filings (RNS).
2023-11-09 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.